Nymox Pharmaceutical Corp (NYMXF)

[cjstocksup]

This is what we needed to counter the short attacks when we had began a new solid base above $5.00 a share. This news is huge. I have never seen any phase 2 or phase 3 studies of any drugs that had such positive results and knowing so many men including family and friends over the years who had to have prostate surgery and one that died this is very good news for everyone. This should get NYMX the analyst coverage we deserve with BUY ratings ahead. The $5.00 to $6.00 a share we saw on last weeks highs seems way too cheap to me with these results.